Back to Directory

Photodynamic Therapy

PDT

Visual ViewRaw Data
Group
Targeted cellular destruction using light-activated drugs for potential senolytic effects.

Photodynamic therapy uses a light-activated drug, or photosensitizer, that is administered systemically or topically. When a specific wavelength of light is applied to the target area, the drug produces a form of oxygen that kills nearby cells. Its relevance to healthspan is based on its experimental potential as a targeted senolytic therapy to selectively destroy dysfunctional senescent cells, which are known drivers of aging.

Verdict

A powerful clinical tool, but highly experimental and risky for longevity.

HEALTHSPAN IMPACT

Experimental

RISK LEVEL

High

EVIDENCE GRADE

C

MONTHLY COST

$500 - $5000

Protocol

  • Experimental protocols are exploring systemic or localized treatments to clear senescent cells, but no standard healthspan protocol exists.

Flags

  • Primarily a clinical treatment for cancer and dermatology, not a standard healthspan therapy.
  • Causes extreme photosensitivity for days or weeks post-treatment, requiring strict sun avoidance.
  • Must only be performed by a qualified medical professional in a clinical setting.
  • Risk of significant pain, swelling, scarring, and blistering at the treatment site.